EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles

Anna Egorova, Svetlana Freund, Iuliia Krylova iD, Anastasia Kislova iD, Anton Kiselev iD

International Journal of Molecular Sciences · 30.10.2025 · 26 (21) · 10582

DOI: 10.3390/ijms262110582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2025. Verfasst von Anna Egorova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics and Gene Therapy, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Mendeleevskaya Line 3, 1…. Hauptthemen laut MEDLINE: Endometriosis, Nanoparticles, RNA, Small Interfering, Receptors, CXCR4. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is a common gynecological condition that affects fertility in many women of reproductive age worldwide. This multifaceted disease exhibits a pathogenesis characterized by hormonal and immune system dysregulations, alongside increased angiogenic activity within the peritoneum. The aberrant proliferation of endometrial tissue outside the uterus is associated with vascularization in ectopic endometriotic lesions. Consequently, RNA interference (RNAi)-based angiogenic therapies targeting the VEGFA gene present a promising strategy for the treatment of endometriosis. To ensure the efficacy of RNAi-based therapy, it is critical to develop carriers capable of precisely delivering small interfering RNA (siRNA) to target cells. Additionally, the instability of polyplexes in vivo must be regarded as a pivotal aspect influencing the success of non-viral delivery. In this study, we introduce ternary polyplexes comprising siRNA and a carrier derived from an arginine–histidine-rich peptide, which is further coated with a glutamate–histidine-rich polymer modified using an SDF-1 chemokine-derived ligand for targeting CXCR4-expressing cells. The physicochemical characteristics of the siRNA-polyplexes, along with cellular toxicity and GFP gene silencing efficacy, were assessed in vitro. The anti-angiogenic potential of anti-VEGFA siRNA-polyplexes was evaluated by measuring the size of endometrial lesions, conducting immunohistochemical staining, and analyzing VEGFA gene expression. For in vivo experiment, a rat model of endometriosis induced by subcutaneous auto-transplantation of uterine tissue was utilized. A significant reduction in the growth of endometriotic implants and silencing of VEGFA gene expression was observed when compared to the saline-treated control group. The results of this study strongly suggest that the developed ternary polyplexes have significant potential as an efficient tool for the development of anti-angiogenic RNAi-based therapies for endometriosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisNanoparticlesRNA, Small InterferingReceptors, CXCR4RNA InterferencePeptidesAnimalsFemaleRatsDisease Models, AnimalVascular Endothelial Growth Factor AHumansRNAi TherapeuticsEndometriumNeovascularization, PathologicRats, Sprague-Dawley

Stichwörter der Autor:innen

CXCR4VEGFAanti-angiogenic therapychemokine-derived peptideendometriosisgene therapypeptide-based carrierssiRNA delivery

Substanzen

RNA, Small InterferingVascular Endothelial Growth Factor AReceptors, CXCR4Peptides

Autor:innen und Institutionen

  • Laboratory of Molecular Genetics and Gene Therapy, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Mendeleevskaya Line 3, 199034 Saint-Petersburg, Russia.
  • Department of Pathology, Pavlov First Saint-Petersburg State Medical University, L'va Tolstogo Street 6-8, 197022 Saint-Petersburg, Russia.

ORCID-Profile: Iuliia Krylova, Anastasia Kislova, Anton Kiselev

Förderung

  • Russian Science Foundation

Zitieren

APA

Egorova, A., Freund, S., Krylova, I., Kislova, A., & Kiselev, A. (2025). Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles. International Journal of Molecular Sciences, 26(21), 10582. https://doi.org/10.3390/ijms262110582

Vancouver

Egorova A, Freund S, Krylova I, Kislova A, Kiselev A. Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles. International Journal of Molecular Sciences. 2025;26(21):10582. doi:10.3390/ijms262110582

BibTeX
@article{Egorova2025,
  author = {Egorova, Anna and Freund, Svetlana and Krylova, Iuliia and Kislova, Anastasia and Kiselev, Anton},
  title = {Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10582},
  doi = {10.3390/ijms262110582}
}
Kostenlos starten →